In an increasingly common practice, assistants, consultants and other hospital employees are charging patients or their insurers hefty fees. NYT reports.» Read More
Wal-Mart Stores earnings are taking a hit as more of its U.S. workers sign up for health-care coverage. Is Obamacare to blame?
The nation's largest employers are projecting health-benefits costs will rise 6.5 percent in 2015, according to a new survey from NBGH.
Reports of Singapore's first case of Ebola have been confirmed as false, the Straits Times reported on Thursday.
The fait accompli attitude of Michael Leavitt, the former GOP governor of Utah, toward Obamacare is drawing criticism from conservatives.
New Jersey Gov. Chris Christie posted on his Facebook page a video showing two of his kids dumping a bucket of ice water on his head.
Propelled by Facebook and Twitter, the ice bucket challenge has become a viral sensation. Now Biogen executives and CNBC are rising to the challenge.
Canada will donate a small quantity of an experimental Ebola vaccine developed in its government lab to the WHO for use in Africa.
Apple has been discussing how its "HealthKit" service will work with health providers.
The FDA approved the first screening test for colon cancer that uses patients' DNA to help spot potentially deadly tumors and growths.
U.S. Pres. Barack Obama and the FDA have approved to send sample doses of an experimental drug to treat Liberian doctors infected with Ebola.
U.S. scientists face legal obstacles and frustrations in trying to study the medical uses of marijuana, the New York Times reports.
All three U.S. laboratories established to fight major public health threats say they are standing by to scale up a treatment for Ebola.
Oracle has sued Oregon over its health insurance exchange, saying officials are using the company's software despite disputed bills.
Twenty-nine state attorneys general have urged the FDA to impose stricter regulations on e-cigarettes,similar to those of traditional cigarettes.
Is the world ready for genetically modified babies? Here's how close we really are, explains Jessica Cussins of the Center for Genetics and Society.
Don't believe the hype that insurance companies are getting squeezed on Obamacare. That's the message from Ezekiel Emanuel, one of the law's architects.
Tekmira Pharmaceutical's stocks have soared since the U.S. Food and Drug Administration cleared its experimental Ebola drug for human use.
The outbreak of the Ebola virus in West Africa is an ‘extraordinary event’ and a public health risk to other countries, WHO has warned.
Pfizer is facing a mounting wave of lawsuits by women who allege that the company knew about possible serious side effects of its drug Lipitor.
Looking to trade on the Ebola scare? Ex-trader Turney Duff offers up what he'd do—and a word of caution.
Get the best of CNBC in your inbox